WLWT: New Ohio breast cancer screening law now in effect
On Friday, Sept. 23, Ohio House Bill 371 went into effect, making it possible for more women in Ohio to have access to additional breast cancer screenings.
House Bill 371, passed by the Ohio General Assembly and signed into law by Gov. Mike DeWine earlier this year, requires insurance companies to cover additional screenings for individuals who are at high risk for breast cancer or have dense breast tissue. The legislation was supported by the advocacy of survivors, UC researcher-physicians and state legislators.
WLWT News spoke with Ann Brown, MD, assistant professor at the University of Cincinnati College of Medicine and a UC Health breast radiologist, and breast cancer survivor Michele Young on the importance of the bill going into effect.
"As a breast radiologist; I see firsthand how breast cancer can be masked by dense tissue," Brown told WLWT. "And we know that this is an area that we fall short in early detection is for patients with dense breasts, so for those patients to get additional screening may be life-saving."
Patient advocate Michele Young was also recently featured in a NBC News/Today Show story. Watch the story here.
Featured photo at top of Ann Brown, MD, from left, Rep. Sedrick Denson, patient Michele Young, Mary Mahoney, MD, and Rep. Jean Schmidt at a press conference celebrating the passage of House Bill 371. Photo/UC Health.
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
Telescope captures information about lonely Jupiter-like gas giant
May 13, 2026
Science outlets highlight a University of Cincinnati student's collaborative discoveries about an exoplanet 901 light years away.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.